• Lilly, Sigilon Therapeutics Announce Collaboration americanpharmaceuticalreview
    April 09, 2018
    Eli Lilly and Company and Sigilon Therapeutics announced a global collaboration to develop encapsulated cell therapies for the potential treatment of type 1 diabetes
PharmaSources Customer Service